Building Evidence for the Future of Clinical Documentation: Aiomics Supports Independent Research at Charité

Prof. Dr. Akira-Sebastian Poncette and Merve Sarica together with Dr. Sven Jungmann at Berlin Institute of Health.

At aiomics, we believe that progress in healthcare depends not on promises but on proof. That’s why we are proud to support independent research at Charité – Universitätsmedizin Berlin, one of Europe’s leading academic medical centers, conducted by the Clinical Implementation Science in Digital Health research group. 

Why This Partnership Matters

Across hospitals and clinics, doctors, nurses, and therapists spend hours every day documenting care. AI-supported systems like aiomics offer new ways to automate and validate this work, but the real question is whether they actually deliver measurable improvements in the realities of clinical practice.

The Clinical Implementation Science in Digital Health Research Group at Charité, led by Prof. Dr. Akira-Sebastian Poncette at the Institute of Medical Informatics, is pioneering research that examines precisely this question: Under what conditions can AI-based documentation systems be implemented safely, be accepted by professionals, and produce tangible efficiency and quality gains?

Independent Evaluation and Shared Values

Aiomics supports this independent scientific evaluation in real-world clinical environments. Charité was chosen because of its reputation for rigorous scientific and ethical standards. 

The research is conducted entirely under Charité’s direction—with full academic independence in study design, data analysis, and publication.

For aiomics, this is not a marketing initiative but a commitment to transparency and scientific accountability.

While digital therapeutics, pharmaceuticals, and medical devices must routinely demonstrate evidence, much of healthcare software still relies on anecdote and testimonials. We want to help change that. Evidence should be the rule, not the exception.

Merve Sarica and Dr Sven Jungmann discussing the User Interface of aiomics.

Rigor Over Rhetoric

As a company led by a physician and a physicist, we are acutely aware of the responsibility that comes with deploying AI in healthcare. Building trustworthy technology requires more than good intentions and attractive interfaces. It requires rigorous, independent scrutiny—even if that means facing uncomfortable results.

Supporting this independent research is therefore a deliberate investment in transparency. 

Our product is still evolving, and that means we are also subjecting ourselves to risk: results may not always align with our expectations. Yet, we firmly believe that only technologies that can withstand this level of scrutiny deserve to become part of everyday care.

Beyond Technology: Understanding Implementation

Prof. Akira Sebastian Poncette

Equally important, Charité’s team will explore how AI-driven tools can best be integrated into clinical workflows. Implementation science reminds us that success in digital health is not only about the algorithm—it’s about people, processes, and context. A product that works in theory must also work in the complex routines of wards, rehabilitation clinics, and outpatient centers.

By studying these dynamics, the research aims to generate practical insights and frameworks that healthcare institutions and future partners can use to introduce new digital tools safely and effectively.

Towards a More Transparent Digital Health Ecosystem

We view this initiative as a step toward a broader movement in digital health—one that values transparency, reproducibility, and real-world outcomes over slogans of “efficiency” and “innovation.”

Our mission at aiomics has always been to make healthcare data flow—transforming fragmented, manual documentation into a validated, interoperable information stream that strengthens care, compliance, and insight. But this flow must be built on trust. Independent evaluation is how that trust is earned.

We are grateful to Charité’s research team and to our early customers who are joining us on this journey. Together, we hope to demonstrate that when science and industry collaborate with integrity, digital innovation in healthcare can truly live up to its promise.

The Charité ‘Implementation Science for Digital Health’ team together with the aiomics founders.